AAM
RMD icon

Arabesque Asset Management’s ResMed RMD Stock Holding History

Arabesque Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,014
Closed -$211K – 105
2022
Q4 		$211K Hold
1,014
– – 0.07% 130
2022
Q3 		$221K Buy
+1,014
New +$231K 0.11% 111
2022
Q1 		– Sell
-1,137
Closed -$296K – 196
2021
Q4 		$296K Buy
+1,137
New +$295K 0.09% 155
2020
Q1 		– Sell
-5,712
Closed -$885K – 123
2019
Q4 		$885K Buy
+5,712
New +$823K 0.34% 96

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Arabesque Asset Management's RMD Position: Q1 2023 in Review

Arabesque Asset Management sold out of ResMed (RMD) in Q1 2023, closing a stake of 1,014 shares — an estimated $211K sold.

Arabesque Asset Management first reported a position in RMD in Q4 2019 and held it in 4 quarters. The position peaked at $885K in Q4 2019. 677 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • Arabesque Asset Management reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
  • Arabesque Asset Management sold 1,014 ResMed shares in Q1 2023, an estimated $211K.
  • Arabesque Asset Management first reported a position in ResMed in Q4 2019 and held it in 4 quarters.
  • Arabesque Asset Management's ResMed position peaked at $885K in Q4 2019.
  • 677 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.